Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 12 Jun 2024
Cannabis use may not be as detrimental to standard posttraumatic stress disorder (PTSD) therapy as previously believed, despite the risks involved with self-medicating for mental health conditions, according to a Rutgers study.
Read Full NewsAripiprazole is associated with a lower risk for hyponatremia compared with olanzapine in patients treated with second-generation antipsychotics, a new cohort study shows.
Researchers evaluate changes in post-transplantation outcomes among patients with relapsed or refractory Hodgkin lymphoma from 2010 to 2022.
In a recent KFF survey, 43% of US adults said they had skipped their medication in the past year because of cost.
1.
Is It Really Cancer? More Concerns About Accelerated Approval; Metformin and Cancer
2.
Pediatric high-grade gliomas: Research reveals effective targeting with avapritinib
3.
In prostate cancer survivorship, sleep disturbances are underappreciated.
4.
Study shows supervised exercise improves strength, physical performance in patients with advanced breast cancer
5.
a cutting-edge cancer diagnostic tool.
1.
Therapeutic Innovations Through Germline Predisposition in Acute Leukemias and Myeloid Neoplasms
2.
Community Survivorship Networks for Long-Term Cancer Wellness
3.
Neuroendocrine Tumors: Case Study on Diagnosis, Treatment Strategies & Patient Management
4.
Targeted Therapies for Breast Cancer: What’s New?
5.
Integrated Insights in Hematology and Quality Improvement
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV
2.
Hands-on Workshop: Hematology
3.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
4.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part III
5.
Learning About Different Treatment Approaches For Acute Lymphoblastic Leukemia
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge